Cargando…
Development and characterization of a novel luciferase based cytotoxicity assay
A simple, accurate, sensitive and robust assay that can rapidly and specifically measure the death of target cells would have applications in many areas of biomedicine and particularly for the development of novel cellular- and immune-therapeutics. In this study, we describe a novel cytotoxicity ass...
Autores principales: | Matta, Hittu, Gopalakrishnan, Ramakrishnan, Choi, Sunju, Prakash, Rekha, Natarajan, Venkatesh, Prins, Ruben, Gong, Songjie, Chitnis, Saurabh D., Kahn, Michael, Han, Xu, Chaudhary, Vishan, Soni, Adam, Sernas, Jennifer, Khan, Prottasha, Wang, Dan, Chaudhary, Preet M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760659/ https://www.ncbi.nlm.nih.gov/pubmed/29317736 http://dx.doi.org/10.1038/s41598-017-18606-1 |
Ejemplares similares
-
A novel thermostable beetle luciferase based cytotoxicity assay
por: Choi, Sunju, et al.
Publicado: (2021) -
A Fast and Sensitive Luciferase-based Assay for Antibody Engineering and Design of Chimeric Antigen Receptors
por: Natarajan, Venkatesh, et al.
Publicado: (2020) -
A novel luciferase-based assay for the detection of Chimeric Antigen Receptors
por: Gopalakrishnan, Ramakrishnan, et al.
Publicado: (2019) -
Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma
por: Gopalakrishnan, Ramakrishnan, et al.
Publicado: (2020) -
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
por: Gopalakrishnan, Ramakrishnan, et al.
Publicado: (2015)